In vitro activity of telavancin and occurrence of vancomycin heteroresistance in isolates from patients enrolled in phase 3 clinical trials of hospital-acquired pneumonia
Kevin M. Krause, Johanne Blais, Stacey R. Lewis, Christopher S. Lunde, Steven L. Barriere, H. David Friedland, Michael M. Kitt, Bret M. BentonVolume:
74
Year:
2012
Language:
english
DOI:
10.1016/j.diagmicrobio.2012.08.010
File:
PDF, 140 KB
english, 2012